|
|
Empirical Micafungin Treatment and Survival Without Invasive Fungal Infection in Adults With ICU-Acquired Sepsis, Candida Colonization, and Multiple Organ Failure The EMPIRICUS Randomized Clinical Trial
Kada Klouche
,
Samir Jaber
,
Jean-Louis Trouillet
,
Fabrice Bruneel
,
Laurent Argaud
et al.
Journal articles
hal-01405822v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Population pharmacokinetics of micafungin in ICU patients with sepsis and mechanical ventilation
Vincent Jullien
,
Elie Azoulay
,
Carole Schwebel
,
Thomas Le Saux
,
Pierre Emmanuel Charles
et al.
Journal articles
hal-01470808v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Clinical Impact of Antifungal Susceptibility, Biofilm Formation and Mannoside Expression of Candida Yeasts on the Outcome of Invasive Candidiasis in ICU: An Ancillary Study on the Prospective AmarCAND2 Cohort
Jean-Pierre Gangneux
,
Muriel Cornet
,
Sébastien Bailly
,
Chantal Fradin
,
Celine Feger
et al.
Journal articles
hal-01978477v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
EMPIRICUS micafungin versus placebo during nosocomial sepsis in Candida multi-colonized ICU patients with multiple organ failures: study protocol for a randomized controlled trial.
Jean-François Timsit
,
Elie Azoulay
,
Muriel Cornet
,
Jean-Pierre Gangneux
,
Vincent Jullien
et al.
Journal articles
inserm-00913515v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|